LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
6.93
-0.02 (-0.29%)
At close: Mar 6, 2026, 4:00 PM EST
6.95
+0.02 (0.29%)
After-hours: Mar 6, 2026, 5:39 PM EST
LifeStance Health Group Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$9.71
Upside
+40.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +29.87% | Mar 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +44.30% | Feb 26, 2026 |
| UBS | UBS | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +73.16% | Feb 26, 2026 |
| Keybanc | Keybanc | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +29.87% | Feb 26, 2026 |
| BTIG | BTIG | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +58.73% | Feb 2, 2026 |
| BTIG | BTIG | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +44.30% | Dec 12, 2025 |
| Barclays | Barclays | Buy Initiates $8 | Buy | Initiates | $8 | +15.44% | Dec 9, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $8 | Buy | Initiates | $8 | +15.44% | Nov 13, 2025 |
| UBS | UBS | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +44.30% | Nov 7, 2025 |
| BTIG | BTIG | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +29.87% | Nov 6, 2025 |
| UBS | UBS | Strong Buy Maintains $8.5 → $9 | Strong Buy | Maintains | $8.5 → $9 | +29.87% | Aug 8, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $8.5 | Hold → Strong Buy | Upgrades | $8.5 | +22.66% | May 27, 2025 |
| Keybanc | Keybanc | Buy Initiates $9 | Buy | Initiates | $9 | +29.87% | Apr 8, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +15.44% | Apr 3, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +44.30% | Dec 16, 2024 |
| Barclays | Barclays | Sell Maintains $6 → $7 | Sell | Maintains | $6 → $7 | +1.01% | Nov 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.